Osterweis Capital Management’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.56M Sell
14,804
-10,436
-41% -$3.24M 0.23% 85
2026
Q2
$7.07M Sell
25,240
-51,743
-67% -$13.6M 0.33% 76
2026
Q1
$20.5M Buy
76,983
+920
+1% +$249K 1.06% 39
2025
Q4
$19.1M Sell
76,063
-2,085
-3% -$554K 0.81% 43
2025
Q3
$22.4M Sell
78,148
-361
-0.5% -$96.7K 1.01% 38
2025
Q2
$20.6M Buy
+78,509
New +$19.1M 0.99% 37

Other funds holding LH

Osterweis Capital Management's LH Position: Q3 2026 in Review

Osterweis Capital Management reduced its Labcorp (LH) stake by 41% in Q3 2026, selling an estimated $3.24M and leaving 14,804 shares worth $4.56M. The position accounts for 0.23% of the portfolio, ranked #85.

Osterweis Capital Management first reported a position in LH in Q2 2025 and has held it in 6 quarters since. The position peaked at $22.4M in Q3 2025. 1,095 funds tracked by Wall St. Rank hold LH as of Q3 2026.

  • Osterweis Capital Management held 14,804 shares of Labcorp worth $4.56M as of Q3 2026.
  • Osterweis Capital Management sold 10,436 Labcorp shares in Q3 2026, an estimated $3.24M.
  • Labcorp made up 0.23% of Osterweis Capital Management's portfolio in Q3 2026, its #85 holding.
  • Osterweis Capital Management first reported a position in Labcorp in Q2 2025 and has held it in 6 quarters since.
  • Osterweis Capital Management's Labcorp position peaked at $22.4M in Q3 2025.
  • 1,095 funds tracked by Wall St. Rank held Labcorp as of Q3 2026.

Based on Osterweis Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.